Solutes transport characteristics in peritoneal dialysis: Variations in glucose and insulin serum levels

Renal Failure

Volumn 30, Issue 2, 2008, Pages 175-179

  Da Silva, Dirceu R ^a   Figueiredo, Ana E ^a   Antonello, Ivan C ^a   De Figueiredo, Carlos E Poli ^a   D'Avila, Domingos O ^a,b  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b NONE   (Brazil)

Author keywords

End stage renal disease; Insulin resistance; Obesity; Renal dialysis; Solutes transport

Indexed keywords

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIALYSATE; DISEASE ASSOCIATION; FEMALE; FLUID BALANCE; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULIN RESISTANCE; KIDNEY FAILURE; MALE; OBESITY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SOLUTE; WEIGHT GAIN;

ADULT; AGED; BIOLOGICAL MARKERS; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIALYSIS SOLUTIONS; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; OSMOTIC PRESSURE; PARTICLE SIZE; PERITONEAL DIALYSIS; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME; WATER-ELECTROLYTE BALANCE;

EID: 39749192489     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220701810307     Document Type: Article

References (28)

1. Grodstein GP, Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW. Glucose absorption during continuous ambulatory peritoneal dialysis. Kidney Int. 1981;19: 564-567.
2. Wolfson M, Jones MR. Nutrition impact of peritoneal dialysis solutions. Miner Electrolyte Metab. 1999;25:333-336.
3. Jolly S, Chatatalsingh C, Bargman J, et al. Excessive weight gain during peritoneal dialysis. Int J Artif Organs. 2001;24:197-202.
4. Heimbürger O. Obesity on PD patients: Causes and management. Contrib Nephrol. 2003;140:91-97.
5. Ruige JB, Assendelft WJJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM. Insulin and risk of cardiovascular disease - a meta-analysis. Circulation. 1998;97:996-1001.
6. Liu J, Rosner M. Lipid abnormalities associated with endstage renal disease. Semin Dial. 2006;19:32-40.
7. Cheng SC, Chu TS, Huang KY, et al. Association of hypertriglyceridemia and insulin resistance in uremic patients undergoing CAPD. Perit Dial Int. 2001;21:282-289.
8. Davies SJ, Brown B, Bryan J, Russell GI. Clinical evaluation of the peritoneal equilibration test: A population-based study. Nephrol Dial Transplant. 1993;8:64-70.
9. Davies SJ, Bryan J, Phillips L, Russell GI. Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant. 1996; 11:498-506.
10. Twardowski ZJ, Nolph KD, Khanna R, et al. Peritoneal equilibration test. Perit Dial Bull. 1987;7:138.
11. Correa-Rotter R, Cueto-Manzano A. The problem of the high transporter: Is survival decreased? Perit Dial Int. 2001;21 (Suppl. 3):75-79.
12. Mujais S, Nolph K, Gokal R, et al. Evaluation and management of ultrafiltration problems in peritoneal dialysis: International Society for Peritoneal Dialysis ad hoc Committee on Ultrafiltr ation Management in Peritoneal Dialysis. Perit Dial Int. 2000;20 (Suppl. 4):5-21.
13. Figueiredo AE, Almeida PB, Pinheiro da Costa BE, d'Avila DO, Poli de Figueiredo CE. Erythrocyte L-arginine uptake in peritoneal dialysis patients: Systems y and y+ L. Adv Perit Dial. 2005;21:2-4.
14. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28:412-419.
15. Katsuki A, Sumida Y, Gabazza EC, et al. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type-2 diabetes. Diabetes Care. 2001;24:362-365.
16. Cueto-Manzano AM, Ofaz-Alvarenga A, Correa-Rotter R. Analysis of the peritoneal equilibration test in México and factors influencing the peritoneal transport rate. Perit Dial Int. 1999;19:45-50.
17. Pecoits-Filho R, Araújo MRT, Lindholm B, et al. Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant. 2002;17:1480-1486.
18. Delarue J, Maingourd C, Couet C, Vidal S, Bagros P, Lamisse F. Effects of oral glucose on intermediary metabolism in continuous ambulatory peritoneal dialysis patients versus healthy subjects. Perit Dial Int. 1998;18:505-511.
19. Lin S-H, Lin Y-F, Kuo S-W, Hsu Y-J, Hung Y-J. Rosiglitazone improves glucose metabolism in nondiabetic uremic patients on CAPD. Am J Kidney Dis. 2003;42:774-780.
20. Tjiong HL, van den Berg J, Wattimena JL, et al. Dialysate as food: Combined amino acid and glucose dialysate improves protein anabolism in renal failure patients on automated peritoneal dialysis. J Am Soc Nephrol. 2005;16:1486-1493.
21. Huang JW, Yen CJ, Chiang HW, Hung KY, Tsai TJ, Wu KD. Adiponectin in peritoneal dialysis patients: A comparison with hemodialysis patients and subjects with normal renal function. Am J Kidney Dis. 2004;43:1047-1055.
22. Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study. Diabetes Care. 1997;20:1087-1092.
23. Lee P, O'Neal D, Murphy B, Best J. The role of abdominal adiposity and insulin resistance in dyslipidemia of chronic renal disease. Am J Kidney Dis. 1997;29:54-65.
24. Becker B, Kronenberg F, Kielstein JT, et al. Renal insulin resistance syndrome, adiponectine and cardiovascular events in patients with kidney disease: The mild and moderate kidney disease study. J Am Soc Nephrol. 2005;16:1091-1098.
25. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW. Insulin resistance, metabolic syndrome and incident cardiovascular events in the Framingham offspring study. Diabetes. 2005;54:3252-3257.
26. Mateijsen MA, van der Wal AC, Hendiks PM, et al. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int. 1999;19:517-525.
27. Combet S, Miyata T, Moulin P, et al. Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Nephrol. 2000;11:717-728.
28. Shoji T, Emoto M, Nishizawa Y. HOMA index to assess insulin resistance in renal failure patients. Nephron. 2001;89:348-349.